If this is your first visit, be sure to check out the FAQ & read the forum rules. To view all forums, post or create a new thread, you must be an AAPC Member. If you are a member and have already registered for member area and forum access, you can log in by clicking here. If you've forgotten your username or password use our password reminder tool. To start viewing messages, select the forum that you want to visit from the selection below..
Does anyone know about the new "JG" modifier requirements for hospitals participating in 340B program? I am trying to determine if this is going to be applicable for just traditional Medicare or Medicare Advantage plans?
I don't have anything to support this, but it appears that it is effective 1/1/18 for outpatient Medicare FFS claims when any status indicator K drugs are involved. It will be required for any 340B hospitals. That's all I've got.